» Articles » PMID: 39200071

Do Organism Profile and Resistance Patterns Change Between First and Subsequent Two-Stage Revision for Periprosthetic Joint Infection?

Overview
Specialty Pharmacology
Date 2024 Aug 29
PMID 39200071
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing antibiotic resistance has been reported as an issue in the treatment of periprosthetic joint infection (PJI). A repeat two-stage revision for recurrent PJI is at high risk of reinfection. However, it is unclear if the microorganism profile plays a role with potentially more resistant or polymicrobial infections. This is a retrospective, single-center analysis of two-stage revisions performed between 2011 and 2017. We identified 46 patients who underwent a repeat resection arthroplasty for recurrent PJI of the same joint after a previous two-stage revision of the same joint at the same department. All microbiological findings were analyzed focusing on microbiological spectrum and resistance testing as well as the potential impact on reinfection-free survival. The most common organism found at the time of recurrent PJI were coagulase-negative (39%) followed by Gram-negative organisms (28%). The risk of polymicrobial infections, difficult-to-treat resistant organisms, and Gram-negative infections increased significantly. Among infections, there was a high percentage of methicillin-resistant species and resistance to oral antibiotics. Patients with Gram-negative organisms had a reduced infection-free survivorship, while resistant organisms were not associated with decreased survival. Patients who undergo a repeat two-stage revision for recurrent PJI have more polymicrobial and resistant organisms, although the impact on survivorship is unclear.

Citing Articles

Novel Method for the Rapid Establishment of Antibiotic Susceptibility Profiles in Bacterial Strains Linked to Musculoskeletal Infections Using Scattered Light Integrated Collector Technology.

Bertheloot D, Nessler V, Assaf E, Amerschlager C, Ali K, Ossendorff R Int J Mol Sci. 2025; 26(4).

PMID: 40004019 PMC: 11855405. DOI: 10.3390/ijms26041553.

References
1.
Xu C, Tan T, Li W, Goswami K, Parvizi J . Reporting Outcomes of Treatment for Periprosthetic Joint Infection of the Knee and Hip Together With a Minimum 1-Year Follow-Up is Reliable. J Arthroplasty. 2020; 35(7):1906-1911.e5. DOI: 10.1016/j.arth.2020.02.017. View

2.
Wimmer M, Hischebeth G, Randau T, Gathen M, Schildberg F, Froschen F . Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections. Diagn Microbiol Infect Dis. 2020; 98(2):115114. DOI: 10.1016/j.diagmicrobio.2020.115114. View

3.
Tarazi J, Chen Z, Scuderi G, Mont M . The Epidemiology of Revision Total Knee Arthroplasty. J Knee Surg. 2021; 34(13):1396-1401. DOI: 10.1055/s-0041-1735282. View

4.
Khan N, Parmar D, Ibrahim M, Kayani B, Haddad F . Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection. Bone Joint J. 2019; 101-B(6_Supple_B):110-115. DOI: 10.1302/0301-620X.101B6.BJJ-2018-1556.R1. View

5.
Kullar R, Chisari E, Snyder J, Cooper C, Parvizi J, Sniffen J . Next-Generation Sequencing Supports Targeted Antibiotic Treatment for Culture Negative Orthopedic Infections. Clin Infect Dis. 2022; 76(2):359-364. PMC: 9839185. DOI: 10.1093/cid/ciac733. View